Mali vs Pakistan: HIV/AIDS deaths averted by antiretroviral therapy
Mali
5,460 deaths
in 2024
Pakistan
4,811 deaths
in 2024
Mali rank
36th
Pakistan rank
38th
HIV/AIDS deaths averted by antiretroviral therapy over time
- Mali
- Pakistan
How they compare
Mali currently reports 5,460 deaths against 4,811 deaths in Pakistan, a difference of 649 deaths.
That makes Mali's figure about 1.1 times Pakistan's.
The two have swapped places 1 time across 35 shared years of data; in 1990 it was Pakistan ahead.
Mali ranks 36th and Pakistan ranks 38th of 157 countries.
Mali has averaged higher in every one of the 4 decades both report.
Head to head by decade
| Decade | Mali | Pakistan | Difference | Ahead |
|---|---|---|---|---|
| 1990s | 0 deaths | 0 deaths | 0 deaths | — |
| 2000s | 1,193 deaths | 49.67 deaths | 1,143 deaths | Mali |
| 2010s | 3,647 deaths | 854.17 deaths | 2,793 deaths | Mali |
| 2020s | 4,734 deaths | 3,244 deaths | 1,489 deaths | Mali |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher hiv/aids deaths averted by antiretroviral therapy, Mali or Pakistan?
- Mali, at 5,460 deaths against 4,811 deaths in Pakistan as of 2024.
- What is the difference in hiv/aids deaths averted by antiretroviral therapy between Mali and Pakistan?
- 649 deaths, with Mali ahead.
- How many years of comparable data are there for Mali and Pakistan?
- 35 years are reported by both, from 1990 to 2024.
- How do Mali and Pakistan rank globally for hiv/aids deaths averted by antiretroviral therapy?
- Mali ranks 36th and Pakistan ranks 38th of 157 countries.
- Where does this data come from?
- Joint United Nations Programme on HIV/AIDS (2026) – with minor processing by Our World in Data, published as HIV/AIDS deaths averted by antiretroviral therapy. Statizoid refreshes it automatically from the source and publishes the full history for both places.
Individual pages
About this data
Number of deaths prevented as a direct result of Antiretroviral Therapy (ART) among people living with HIV. It is calculated by comparing the observed mortality rates in individuals receiving ART to the estimated mortality rates in the absence of such treatment. This is the central estimate.